Merck Punches Back In Fosamax Case
Facing thousands of product liability suits over Fosamax, Merck has fired back in court papers and formally rejected allegations that the osteoporosis drug leads to the painful deterioration of the jaw....To view the full article, register now.
Already a subscriber? Click here to view full article